AJJ — Asian American Medical Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2018 August 31st | R2019 August 31st | 2020 August 31st | R2021 August 31st | 2022 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | ARS |
Standards: | IFRS | IFRS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.5 | 7.67 | 4.82 | 1.24 | 0.808 |
Cost of Revenue | |||||
Gross Profit | 7.11 | 3.37 | 1.07 | 0.659 | 0.355 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16 | 9.8 | 7.49 | 6.82 | 1.58 |
Operating Profit | 1.49 | -2.12 | -2.67 | -5.58 | -0.771 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.9 | -2.03 | -2.58 | -5.65 | -0.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.07 | -2.03 | -2.58 | -5.65 | -0.79 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1.95 | -2.05 | -2.46 | -5.86 | -0.79 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.95 | -2.05 | -2.46 | -5.86 | -0.79 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.003 | -0.006 | -0.015 | -0.017 | -0.002 |